GO:0003338 metanephros morphogenesis: Developmental Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003338 metanephros morphogenesis describes the developmental process that generates and organizes the anatomical structures of the metanephros, the embryonic precursor of the permanent mammalian kidney.
• The process depends on reciprocal inductive interactions between the ureteric bud and the metanephric mesenchyme, leading to ureteric branching and nephron formation.
• Key molecular players include GDNF, RET, WNT9B, WNT4, SIX1, PAX2, and BMP4, which orchestrate branching morphogenesis and mesenchymal-to-epithelial transition.
• Disruption of metanephros morphogenesis causes congenital anomalies of the kidney and urinary tract (CAKUT), including renal agenesis and hypoplasia.
• Human metanephros development has been mapped across Carnegie stages, providing a spatiotemporal framework for studying normal and abnormal kidney formation.
• CRISPR-based knockout, knock-in, and overexpression models enable functional dissection of genes driving metanephros morphogenesis.
Description
Metanephros morphogenesis (GO:0003338) is the biological process that generates and organizes the anatomical structures of the metanephros, the definitive embryonic kidney of amniotes. This process transforms undifferentiated intermediate mesoderm into a functional organ through a series of coordinated morphogenetic events, including ureteric bud outgrowth, branching morphogenesis, and nephron differentiation. Understanding metanephros morphogenesis is fundamental to developmental biology and nephrology because defects in this process underlie a spectrum of congenital kidney malformations. Research into this term spans classical embryology, molecular genetics, and modern genome editing, with model organisms and human embryonic specimens providing complementary insights. The metanephros arises from the intermediate mesoderm and depends on reciprocal inductive signals between the ureteric bud and the metanephric mesenchyme. The ureteric bud invades the metanephric mesenchyme and undergoes iterative branching to form the collecting system, while the mesenchyme condenses and undergoes mesenchymal-to-epithelial transition to form nephrons. Disruption of these events leads to renal agenesis, hypoplasia, or dysplasia, highlighting the clinical relevance of this GO term. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of metanephros morphogenesis, its molecular regulation, associated diseases, and experimental approaches for its study.
metanephros morphogenesis At A Glance
| GO ID | GO:0003338 |
|---|---|
| GO term | metanephros morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of metanephric anatomical structures |
| Key tissues | Ureteric bud, metanephric mesenchyme |
| Key processes | Branching morphogenesis, mesenchymal-to-epithelial transition, nephron patterning |
| Related disorders | Congenital anomalies of the kidney and urinary tract (CAKUT) |
What Is GO:0003338?
GO:0003338 metanephros morphogenesis is defined as the process in which the anatomical structures of the metanephros are generated and organized. In other words, it encompasses all cellular and molecular events that build the definitive kidney, from the initial outgrowth of the ureteric bud to the establishment of a patterned organ with distinct cortical and medullary regions.
Why Is metanephros morphogenesis Important in Cell Biology?
Metanephros morphogenesis is essential for the formation of the permanent kidney, and its disruption causes a range of congenital kidney defects that affect millions of newborns worldwide. Understanding this process provides insights into normal organogenesis, stem cell biology, and regenerative medicine, while also identifying therapeutic targets for kidney disease.
• Defects in metanephros morphogenesis cause renal agenesis, hypoplasia, and dysplasia, which are leading causes of pediatric kidney failure.
• The process serves as a paradigm for studying reciprocal tissue inductions and branching morphogenesis in organ development.
• Key signaling pathways (GDNF/RET, WNT, BMP) are conserved across species, enabling translational research.
• Human metanephros development has been staged using Carnegie criteria, aiding prenatal diagnosis and developmental biology.
• Abnormalities in metanephros morphogenesis are linked to Wilms tumor and other pediatric renal cancers.
• Understanding this process supports efforts to generate kidney organoids and bioengineered kidneys for transplantation.
• Genetic variants in genes controlling metanephros morphogenesis are frequent in CAKUT patients.
• Modeling metanephros morphogenesis in vitro enables drug screening and nephrotoxicity testing.
• The process informs regenerative strategies for acute and chronic kidney disease.
• Comparative studies across vertebrates reveal evolutionary conservation of kidney developmental mechanisms.
What Happens During metanephros morphogenesis?
Ureteric Bud Outgrowth and Induction
In simple terms: The kidney starts when a tube called the ureteric bud grows out from the Wolffian duct and signals to nearby tissue to form the kidney.
Metanephros morphogenesis begins when the ureteric bud evaginates from the Wolffian duct and invades the metanephric mesenchyme. This outgrowth is induced by GDNF secreted by the mesenchyme, which activates the RET receptor tyrosine kinase on the ureteric bud. Disruption of GDNF/RET signaling results in renal agenesis, underscoring its essential role.
Branching Morphogenesis of the Collecting System
In simple terms: The ureteric bud repeatedly splits to form the tree-like collecting ducts of the kidney.
Once inside the mesenchyme, the ureteric bud undergoes iterative branching to generate the urinary collecting system. This branching is regulated by reciprocal signals from the mesenchyme, including WNT9B and BMP4, and is modulated by extracellular matrix components. Human embryonic studies have detailed the branching pattern across Carnegie stages.
Mesenchymal-to-Epithelial Transition and Nephron Formation
In simple terms: Some mesenchymal cells transform into epithelial cells and organize into nephrons, the filtering units of the kidney.
Induced by ureteric bud signals, a subset of metanephric mesenchymal cells condenses and undergoes mesenchymal-to-epithelial transition (MET) to form renal vesicles, which then differentiate into nephrons. Key regulators include WNT4, SIX1, PAX2, and LHX1. This process is essential for establishing the filtration units of the kidney.
Vascularization and Patterning
In simple terms: Blood vessels grow into the developing kidney to supply it with blood.
Vascularization of the metanephros involves the ingrowth of endothelial cells and the formation of the renal artery and its branches. This process is coordinated with nephron formation and is critical for kidney function. Three-dimensional reconstructions of human embryos have revealed the spatial relationship between the metanephros and adjacent organs, including the renal arteries.
Functional Maturation
In simple terms: The kidney becomes fully functional and starts producing urine.
As nephrons and collecting ducts mature, the metanephros becomes functional and begins urine production. Functional development of the meso- and metanephros has been studied in animal models, revealing the timeline of glomerular filtration and tubular transport. This maturation is essential for maintaining fluid and electrolyte balance in the fetus and neonate.
Key Genes Involved in GO:0003338 metanephros morphogenesis
The following genes are central to metanephros morphogenesis, as supported by experimental evidence from animal models and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GDNF | Secreted factor that induces ureteric bud outgrowth | Knockout causes renal agenesis; target for CAKUT studies |
| RET | Receptor tyrosine kinase for GDNF | Mutations linked to renal agenesis and Hirschsprung disease |
| WNT9B | Secreted signal from ureteric bud to mesenchyme | Essential for mesenchymal induction and nephron formation |
| WNT4 | Regulates MET and nephron differentiation | Knockout leads to failure of nephron formation |
| SIX1 | Transcription factor in metanephric mesenchyme | Mutations associated with branchio-oto-renal syndrome |
| PAX2 | Transcription factor for ureteric bud and mesenchyme | Mutations cause renal coloboma syndrome |
| BMP4 | Modulates branching morphogenesis | Dysregulation leads to renal hypoplasia |
| LHX1 | Transcription factor required for nephron formation | Knockout results in renal agenesis |
| WT1 | Transcription factor in metanephric mesenchyme | Mutations cause Wilms tumor and nephrotic syndrome |
| FGF8 | Growth factor for ureteric bud outgrowth | Regulates branching and nephron number |
| GATA3 | Transcription factor in ureteric bud | Mutations linked to renal dysplasia |
| EMX2 | Transcription factor in ureteric bud | Knockout causes renal agenesis |
| SALL1 | Transcription factor in metanephric mesenchyme | Mutations cause Townes-Brocks syndrome |
| HNF1B | Transcription factor for ureteric bud branching | Mutations associated with renal cysts and diabetes |
| VEGFA | Angiogenic factor for vascularization | Essential for renal vascular development |
| PDGFB | Growth factor for mesangial cell recruitment | Knockout leads to glomerular defects |
| ANGPT1 | Regulates vascular stabilization | Involved in renal vascular patterning |
How Is metanephros morphogenesis Regulated?
Metanephros morphogenesis is regulated by a complex network of signaling pathways, including GDNF/RET, WNT, BMP, FGF, and Notch. These pathways are modulated by transcription factors such as PAX2, SIX1, WT1, and LHX1, which control gene expression in a spatiotemporal manner. Extracellular matrix components and cell adhesion molecules also influence branching and MET. Additionally, mechanical forces and fluid flow may contribute to tubule formation.
metanephros morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RET | Renal agenesis, Hirschsprung disease | Ret knockout mouse; CRISPR KO in human iPSCs |
| PAX2 | Renal coloboma syndrome | Pax2 mutant mouse; patient-derived organoids |
| WT1 | Wilms tumor, nephrotic syndrome | Wt1 conditional KO mouse; kidney organoids |
| HNF1B | Renal cysts and diabetes syndrome | Hnf1b knockout mouse; CRISPR knock-in of patient mutations |
| SIX1 | Branchio-oto-renal syndrome | Six1 knockout mouse; overexpression in cell models |
Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
Disruptions in metanephros morphogenesis are a major cause of CAKUT, which includes renal agenesis, hypoplasia, dysplasia, and obstructive uropathies. Mutations in genes such as RET, GDNF, PAX2, SIX1, and HNF1B have been identified in CAKUT patients. These anomalies are leading causes of chronic kidney disease in children.
Wilms Tumor and Pediatric Renal Cancer
Aberrant metanephros morphogenesis can lead to Wilms tumor, a pediatric kidney cancer thought to arise from persistent embryonic rests. Mutations in WT1 and other developmental genes are associated with Wilms tumor, highlighting the link between developmental pathways and cancer.
Renal Vascular Anomalies
Defects in vascularization during metanephros morphogenesis can result in renal artery anomalies, which may cause hypertension and renal ischemia. Three-dimensional reconstructions of human embryos have revealed the complex morphogenesis of renal arteries and their relationship to the metanephros.
From metanephros morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X drive ureteric bud branching? | Knockout mouse or CRISPR KO in ureteric bud organoids |
| Does mutation Y cause CAKUT? | Point-mutation knock-in in human iPSCs followed by kidney organoid differentiation |
| Where is protein Z expressed during metanephros development? | Tagged knock-in (e.g., GFP) in mouse or human embryonic stem cells |
| Can overexpression of gene A rescue branching defects? | Overexpression in metanephric mesenchyme cultures or organoids |
| What is the role of gene B in nephron formation? | Conditional knockout in metanephric mesenchyme |
| How does gene C affect vascularization? | Endothelial-specific knockout in mouse embryos |
How to Study the metanephros morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Cell fate and contribution to structures | Identifying progenitor pools in metanephros |
| 3D imaging | Spatial organization of tissues | Mapping human metanephros development |
| Single-cell RNA-seq | Gene expression at single-cell level | Discovering new regulators of morphogenesis |
| Organoid culture | Self-organization and differentiation | Modeling kidney development and disease |
| CRISPR screening | Gene function in morphogenesis | Identifying essential genes for branching |
| Immunohistochemistry | Protein localization | Validating gene expression patterns |
| In situ hybridization | mRNA localization | Detailing spatiotemporal expression |
| Electron microscopy | Ultrastructure of developing nephrons | Studying filtration barrier formation |
Lineage Tracing and Genetic Fate Mapping
Lineage tracing using Cre-loxP systems in mice allows researchers to follow the fate of ureteric bud and metanephric mesenchyme cells during morphogenesis. This method reveals the cellular origins of different kidney structures and is essential for understanding how progenitor cells contribute to organ formation.
Three-Dimensional Imaging and Reconstruction
Advanced imaging techniques, such as optical projection tomography and three-dimensional reconstruction from serial sections, have been used to visualize human metanephros development across Carnegie stages. These methods provide spatial context for gene expression and morphological changes.
Organoid and Cell Culture Models
Kidney organoids derived from pluripotent stem cells recapitulate key aspects of metanephros morphogenesis, including ureteric bud branching and nephron formation. These models enable high-throughput genetic screens and drug testing.
Transcriptomics and Single-Cell RNA Sequencing
Single-cell RNA sequencing has been applied to human and mouse metanephros to identify cell types and gene expression programs driving morphogenesis. This approach reveals novel regulators and cellular heterogeneity.
How CRISPR Can Be Used to Study GO:0003338 metanephros morphogenesis
Knockout
CRISPR knockout of genes such as GDNF, RET, or PAX2 in mouse embryos or human iPSCs can recapitulate renal agenesis or hypoplasia, providing causal evidence for their role in metanephros morphogenesis. Knockout organoids can be used to study branching defects.
Point Mutation
Introducing patient-specific point mutations (e.g., in RET or HNF1B) via CRISPR knock-in allows researchers to model CAKUT and study the functional impact of missense variants on protein function during kidney development.
Knock-in
Tagged knock-in of fluorescent reporters (e.g., GFP) into endogenous loci enables live imaging of gene expression and protein localization during metanephros morphogenesis. This approach is valuable for tracking cell lineages and dynamic processes.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of candidate genes (e.g., WNT4, SIX1) can test whether increased dosage rescues or exacerbates morphogenetic defects, helping to establish sufficiency.
How EDITGENE Supports metanephros morphogenesis Research
Researchers studying metanephros morphogenesis-related genes often need to determine whether a candidate gene is causally involved in kidney development or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for metanephros morphogenesis research.
Frequently Asked Questions About metanephros morphogenesis
What is metanephros morphogenesis?
Metanephros morphogenesis (GO:0003338) is the developmental process that generates and organizes the anatomical structures of the metanephros, the embryonic kidney.
What genes are involved in metanephros morphogenesis?
Key genes include GDNF, RET, WNT9B, WNT4, SIX1, PAX2, BMP4, and WT1, among others.
What diseases are associated with defects in metanephros morphogenesis?
Defects cause congenital anomalies of the kidney and urinary tract (CAKUT), including renal agenesis and hypoplasia, as well as Wilms tumor.
How is metanephros morphogenesis studied?
It is studied using animal models, human embryonic specimens, organoids, lineage tracing, and CRISPR-based gene editing.
What is the role of GDNF in metanephros morphogenesis?
GDNF secreted by the metanephric mesenchyme induces ureteric bud outgrowth by activating RET signaling.
What is the ureteric bud?
The ureteric bud is an outgrowth of the Wolffian duct that invades the metanephric mesenchyme and branches to form the collecting system.
What is mesenchymal-to-epithelial transition in kidney development?
MET is the process by which metanephric mesenchymal cells transform into epithelial cells to form nephrons.
Can CRISPR be used to study metanephros morphogenesis?
Yes, CRISPR knockout, knock-in, and overexpression models enable functional studies of genes in kidney development.
What are the Carnegie stages of metanephros development?
Carnegie stages are a standardized system for staging human embryos; metanephros development has been mapped across these stages.
What are kidney organoids?
Kidney organoids are three-dimensional cell cultures derived from pluripotent stem cells that recapitulate aspects of metanephros morphogenesis.
Conclusion
Metanephros morphogenesis (GO:0003338) is a fundamental developmental process that builds the permanent kidney through coordinated signaling and morphogenetic events. Its disruption leads to congenital kidney anomalies and pediatric cancers, making it a critical area of research. Advances in CRISPR gene editing and organoid technology are accelerating the discovery of new regulators and therapeutic targets. EDITGENE provides essential tools and services to support this research, from knockout models to bioinformatics analysis.
References
- 1. Davidson AJ et al.. 2019. Turning mesoderm into kidney.. Semin Cell Dev Biol 91:86-93 PMID: 30172050
- 2. Hammerman MR. 2001. Growing kidneys.. Curr Opin Nephrol Hypertens 10(1):13-7 PMID: 11195045
- 3. Ishiyama H et al.. 2018. Branching morphogenesis of the urinary collecting system in the human embryonic metanephros.. PLoS One 13(9):e0203623 PMID: 30192900
- 4. Kuure S et al.. 2000. Kidney morphogenesis: cellular and molecular regulation.. Mech Dev 92(1):31-45 PMID: 10704886
- 5. Moritz KM et al.. 1999. Functional development of the meso- and metanephros.. Pediatr Nephrol 13(2):171-8 PMID: 10229008
- 6. Guimo F et al.. 2024. Unraveling Renal Arteries Morphogenesis from Tridimensional Human Embryos Reconstruction.. Ann Vasc Surg 108:65-75 PMID: 38942378
- 7. Smyth IM. 2021. Development of the metanephric kidney.. Curr Top Dev Biol 143:111-150 PMID: 33820620
- 8. Ishiyama H et al.. 2019. Spatial Relationship Between the Metanephros and Adjacent Organs According to the Carnegie Stage of Development.. Anat Rec (Hoboken) 302(11):1901-1915 PMID: 30809945
